Back to Journals » Psoriasis: Targets and Therapy » Volume 6

Management of scalp psoriasis: current perspectives

Authors Blakely K, Gooderham M

Received 23 November 2015

Accepted for publication 12 January 2016

Published 29 March 2016 Volume 2016:6 Pages 33—40

DOI https://doi.org/10.2147/PTT.S85330

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Prof. Dr. Jean Chamcheu

Peer reviewer comments 2

Editor who approved publication: Professor Uwe Wollina


Kim Blakely,1 Melinda Gooderham2

1Faculty of Medicine, University of Toronto, Toronto, ON, Canada; 2Skin Centre for Dermatology, Peterborough, ON, Canada

Abstract: Psoriasis is a chronic inflammatory condition. The age of onset, chronicity, physical, and psychosocial consequences of the disease cause psoriasis to have a significant impact on patient quality of life. Scalp psoriasis is no different, and effective treatment results in an improvement in quality of life. Successful management of scalp psoriasis includes topical therapies that are acceptable to the patient for mild-to-moderate disease, and systemic therapies for recalcitrant or moderate-to-severe disease. The most effective topical therapies are corticosteroid products, or combination products with calcipotriol and corticosteroid. Newer vehicle options provide more attractive and pleasing products for patients and may improve adherence. The current perspectives for management of scalp psoriasis are discussed including available data for systemic therapy of severe disease.

Keywords: psoriasis, scalp psoriasis, topical therapies, systemic therapies, biologics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]